Kymera Therapeutics Inc (KYMR)

Finanzdaten der Kymera Therapeutics Inc-Aktie (KYMR)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	100.00%-	65.00	34.37	2.87	2.76
Cost Of Revenue	100.00%-	65.00	34.37	2.87	2.76
	4.71%147.23	140.61	118.52	100.77	95.29
Research and Development	7.56%128.51	119.48	98.16	83.83	74.09
Operating Income/Loss	94.73%-147.23	-75.61	-84.15	-97.90	-92.52
	115.65%-132.00	-61.21	-69.23	-86.98	-82.18
Attributable To Parent	115.65%-132.00	-61.21	-69.23	-86.98	-82.18
Available To Common Stockholders, Basic	115.65%-132.00	-61.21	-69.23	-86.98	-82.18
Basic Average Shares	1.96%100.10	98.18	97.53	1.84	87.30
Diluted Average Shares	1.96%100.10	98.18	97.53	1.84	87.30
Basic Earnings Per Share	112.90%-1.32	-0.62	-0.71	-0.98	-0.94
Diluted Earnings Per Share	112.90%-1.32	-0.62	-0.71	-0.98	-0.94